IgE binding to its receptors induces tumor-associated macrophages (TAMs) and monocytes to secrete high levels of cytokines, such as TNF-α, IL-1β, and MCP-1, which enhance ADCC against tumor cells (325–328). Here, CCL2 is linked to neoplasm.